CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
High ImpactOriginal article

STAT+: AstraZeneca, Ionis report major trial failure with heart disease drug

Data ReadoutnegativeNegative
AI Analysis

Summary

AstraZeneca and Ionis reported a major trial failure for a heart disease drug in a competitive market segment.

Clinical Trial Data

Primary Endpoint

Not Met

Outcome Details

trial failure

Importance:8/10
Sentiment:
-0.80
clinical trial failureheart diseasepartnership
Related Companies

Read the original article

Published by STAT News on July 9, 2026 9:13 AM

Read Original